digplanet beta 1: Athena
Share digplanet:

Agriculture

Applied sciences

Arts

Belief

Business

Chronology

Culture

Education

Environment

Geography

Health

History

Humanities

Language

Law

Life

Mathematics

Nature

People

Politics

Science

Society

Technology

Quinacrine.svg
Systematic (IUPAC) name
(RS)-N′-(6-Chloro-2-methoxy-acridin-9-yl)-N,N-diethylpentane-1,4-diamine
Clinical data
Trade names Atabrine
AHFS/Drugs.com Micromedex Detailed Consumer Information
Legal status
?
Pharmacokinetic data
Protein binding 80-90%
Half-life 5 to 14 days
Identifiers
CAS number 83-89-6 YesY
ATC code P01AX05 QP51AX04
PubChem CID 237
DrugBank DB01103
ChemSpider 232 YesY
UNII H0C805XYDE YesY
ChEBI CHEBI:8711 YesY
ChEMBL CHEMBL7568 YesY
PDB ligand ID QUN (PDBe, RCSB PDB)
Chemical data
Formula C23H30ClN3O 
Mol. mass 399.957 g/mol
 YesY (what is this?)  (verify)

Mepacrine (INN; also called quinacrine in the United States and Atabrine (trade name) is a drug with several medical applications. It is related to mefloquine.

Medical uses[edit]

These men didn't take their Atabrine (as anti-malaria drug) ; This sign was posted at the 363rd Station Hospital

The main uses of mepacrine are as an antiprotozoal, antirheumatic and an intrapleural sclerosing agent.[1]

Antiprotozoal use include targeting giardiasis, where mepacrine is indicated as a primary agent for patients with metronidazole-resistant giardiasis and patients who should not receive or can not tolerate metronidazole. Giardiasis that is very resistant may even require a combination of mepacrine and metronidazole.[1]

Mepacrine is also used "off-label" for the treatment of systemic lupus erythematosus,[2] indicated in the treatment of discoid and subcutaneous lupus erythematosus, particularly in patients unable to take chloroquine derivatives.[1]

As an intrapleural sclerosing agent, it is used as pneumothorax prophylaxis in patients at high risk of recurrence, e.g., cystic fibrosis patients.[1]

Mepacrine is not the drug of choice because side effects are common, including toxic psychosis, and may cause permanent damage. See mefloquine for more information.

In addition to medical applications, mepacrine is an effective in vitro research tool for the epifluorescent visualization of cells, especially platelets. Mepacrine is a green fluorescent dye taken up by most cells. Platelets store mepacrine in dense granules.[3]

Mechanism[edit]

Its mechanism of action against protozoa is uncertain, but it is thought to act against the protozoan's cell membrane.

It is known to act as a histamine N-methyltransferase inhibitor.

It also inhibits NF-κB and activates p53.

History of uses[edit]

Antiprotozoal[edit]

Mepacrine was initially approved in the 1930s as an antimalarial drug. It was used extensively during the second World War by US marines fighting in the Far East to prevent malaria.[4]

This antiprotozoal is also approved for the treatment of giardiasis (an intestinal parasite),[5] and has been researched as an inhibitor of phospholipase A2.

Scientists at Bayer in Germany first synthesised mepacrine in 1931. The product was one of the first synthetic substitutes for quinine although later superseded by chloroquine.

Anthelmintics[edit]

In addition it has been used for treating tapeworm infections.[6]

Creutzfeldt-Jakob disease[edit]

Mepacrine has been shown to bind to the prion protein and prevent the formation of prion aggregates in vitro,[7] and full clinical trials of its use as a treatment for Creutzfeldt-Jakob disease are under way in the United Kingdom and the United States. Small trials in Japan have reported improvement in the condition of patients with the disease,[8] although other reports have shown no significant effect,[9] and treatment of scrapie in mice and sheep has also shown no effect.[10][11] Possible reasons for the lack of an in-vivo effect include inefficient penetration of the blood brain barrier, as well as the existence of drug-resistant prion proteins that increase in number when selected for by treatment with mepacrine.[12]

Non-surgical sterilization for women[edit]

The use of mepacrine for non-surgical sterilization for women has also been studied. The first report of this method claimed a first year failure rate of 3.1%.[13] However, despite a multitude of clinical studies on the use of mepacrine and female sterilization, no randomized, controlled trials have been reported to date and there is some controversy over its use.[1]

Pellets of mepacrine are inserted through the cervix into a woman's uterine cavity using a preloaded inserter device, similar in manner to IUCD insertion. The procedure is undertaken twice, first in the proliferative phase, 6 to 12 days following the first day of the menstrual cycle and again one month later. The sclerosing effects of the drugs at the utero-tubal junctions (where the Fallopian tubes enter the uterus) results in scar tissue forming over a six week interval to close off the tubes permanently.

In the United States, this method has undergone Phase I clinical testing. The FDA has waived the necessity for Phase II clinical trials because of the extensive data pertaining to other uses of mepacrine. The next step in the FDA approval process in the United States is a Phase III large multi-center clinical trial. The method is currently used off-label.

Many peer reviewed studies suggest that[14] mepacrine sterilization (QS) is potentially safer than surgical sterilization.[15][16] Nevertheless, in 1998 the Supreme Court of India banned the import or use of the drug, allegedly based on reports that it could cause cancer or ectopic pregnancies.[17]

References[edit]

  1. ^ a b c d e Drugs.com: Quinacrine. Retrieved on August 24, 2009.
  2. ^ Toubi E, Kessel A, Rosner I, Rozenbaum M, Paran D, Shoenfeld Y (2006). "The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus". Scand. J. Immunol. 63 (4): 299–303. doi:10.1111/j.1365-3083.2006.01737.x. PMID 16623930. 
  3. ^ Wall JE, Buijs-Wilts M, Arnold JT, et al. (1995). "A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents.". Br J Haematol 89 (2): 380–385. doi:10.1111/j.1365-2141.1995.tb03315.x. 
  4. ^ Baird JK (2011). "Resistance to chloroquine unhinges vivax malaria therapeutics.". Antimicrob Agents Chemother 55 (5): 1827–1830. doi:10.1128/aac.01296-10. 
  5. ^ Canete R, Escobedo AA, Gonzalez ME, Almirall P (2006). "Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children". World J. Gastroenterol. 12 (39): 6366–70. PMID 17072963. 
  6. ^ "quinacrine" at Dorland's Medical Dictionary
  7. ^ Doh-Ura K, Iwaki T, Caughey B (May 2000). "Lysosomotropic Agents and Cysteine Protease Inhibitors Inhibit Scrapie-Associated Prion Protein Accumulation". J Virol 74 (10): 4894–7. doi:10.1128/JVI.74.10.4894-4897.2000. PMC 112015. PMID 10775631. 
  8. ^ Kobayashi Y, Hirata K, Tanaka H, Yamada T (July 2003). "[Quinacrine administration to a patient with Creutzfeldt-Jakob disease who received a cadaveric dura mater graft--an EEG evaluation]". Rinsho Shinkeigaku 43 (7): 403–8. PMID 14582366. 
  9. ^ Haïk S, Brandel J, Salomon D, Sazdovitch V, Delasnerie-Lauprêtre N, Laplanche J, Faucheux B, Soubrié C, Boher E, Belorgey C, Hauw J, Alpérovitch A (28 December 2004). "Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects". Neurology 63 (12): 2413–5. doi:10.1212/01.wnl.0000148596.15681.4d. PMID 15623716. 
  10. ^ Barret A, Tagliavini F, Forloni G, Bate C, Salmona M, Colombo L, De Luigi A, Limido L, Suardi S, Rossi G, Auvré F, Adjou K, Salès N, Williams A, Lasmézas C, Deslys J (August 2003). "Evaluation of Quinacrine Treatment for Prion Diseases". J Virol 77 (15): 8462–9. doi:10.1128/JVI.77.15.8462-8469.2003. PMC 165262. PMID 12857915. 
  11. ^ Gayrard V, Picard-Hagen N, Viguié C, Laroute V, Andréoletti O, Toutain P (February 2005). "A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie". Br J Pharmacol 144 (3): 386–93. doi:10.1038/sj.bjp.0706072. PMC 1576015. PMID 15655516.  - Abstract
  12. ^ Ghaemmaghami S, Ahn M, Lessard P, Giles K, Legname G, et al. (November 2009). Mabbott, Neil, ed. "Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions". PLoS Pathogens 5 (11): 2413–5. doi:10.1371/journal.ppat.1000673. PMC 2777304. PMID 19956709. 
  13. ^ Zipper J, Cole LP, Goldsmith A, Wheeler R, Rivera M. (1980). "Quinacrine hydrochloride pellets: preliminary data on a nonsurgical method of female sterilisation". Asia Oceania J. Obstet. Gynaecol. 18 (4): 275–90. PMID 6109672. 
  14. ^ International Journal of Gynecology and Obstetrics (October 2003). "Quinacrine Sterilization: Reports on 40,252 cases". London: Elsevier. Vol 83 (Suppl. 2). 
  15. ^ Sokal, D.C., Kessel. E., Zipper. J., and King. T. (1994). "Quinacrine: Clinical experience". A background paper for the WHO consultation on the development of new technologies for female sterilization. 
  16. ^ Peterson, H.B., Lubell, L., DeStefano, F., and Ory, H.W. (1983). "The safety and efficacy of tubal sterilization: an international overview". Int J. Gynaecol. Obstet. 21 (2): 139–44. doi:10.1016/0020-7292(83)90051-6. PMID 6136433. 
  17. ^ George, Nirmala (July 25, 1998). "Govt drags feet on quinacrine threat". Indian Express. .

External links[edit]


Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/Mepacrine — Please support Wikipedia.
This page uses Creative Commons Licensed content from Wikipedia. A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.
2 videos found

What Is The Definition Of Quinacrine Medical School Terminology Dictionary

Visit our website for text version of this Definition and app download. http://www.medicaldictionaryapps.com Subjects: medical terminology, medical dictionar...

como cortar una botella con un hilo

use hilo de algodon.

2 videos found

60 news items

Ithaca Journal

Ithaca Journal
Mon, 10 Nov 2014 15:03:30 -0800

That meant avoiding dangers just as deadly as enemy fire — taking daily doses of Mepacrine to avoid malaria, and limiting exposure to the mosquitoes infected with dengue fever. Broiled by heat and lacerated by bugs, the commandos pushed into enemy ...
 
Medscape
Thu, 25 Sep 2014 21:18:45 -0700

Giuseppina Abignano, MD, PhD, Nigel Scott, MD, Frank A. Wollheim, MD, PhD, FRCP, Paul Emery, MD, MA, FRCP, Maya H. Buch, PhD, MBChB, FRCP, Francesco Del Galdo, MD, PhD. Disclosures. J Clin Rheumatol. 2014;20(5):278-282. Print. Abstract and ...

Onislam.net

Onislam.net
Thu, 24 Apr 2014 23:33:29 -0700

Malaria has been categorized as complicated malaria and uncomplicated malaria which can be treated with various doses of different medicines like Artemether , Artesunate, Chloroquin, Bulaquine, Mepacrine, Proguanil etc. These drugs are viable in ...
 
The Australian
Sun, 19 Jan 2014 05:05:47 -0800

"Then I tried him on a drug called Mepacrine (used in India for giardiasis, a protozoal infection). He received 40 times the human dose three times a day and in 24 hours he had stopped scouring. "I thought this was the answer but Colorado Draw was back ...

Laboratory Equipment

Laboratory Equipment
Tue, 20 Aug 2013 05:55:18 -0700

This image shows women workers at a pharmaceuticals factory near London packing Mepacrine pills — or Atabrine as it is known in the U.S. — into boxes, 100 at a time, for dispatch overseas. Mepacrine is used to fight protozoa infections. There is a ...
 
ScienceBlogs (blog)
Thu, 25 Feb 2010 09:46:08 -0800

Some antimalarial drugs such as Mepacrine, an anti-tumoral drug Iododoxorubicin and even Tetracycline are being considered potential for anti-prion therapy. Some of these drugs have been tested on animal models and cell cultures, and have shown robust ...
 
Wirral Globe
Mon, 14 Jan 2013 08:58:06 -0800

"We had to take Mepacrine tablets every day which made your skin turn yellow." Matthew and crew were sent to a camp in Darjeeling where they rested up before sailing to Bangkok to pick up supplies of rice which they took on to Singapore following the ...
 
PR Web (press release)
Mon, 26 Nov 2012 01:56:15 -0800

This is a global, multi-center, randomized, placebo-controlled study to evaluate adverse events of special interest in adults with active, autoantibody-positive systemic lupus erythematosus (SLE) treated with a new drug plus standard therapy vs placebo ...
Loading

Oops, we seem to be having trouble contacting Twitter

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!

Searchlight Group

Digplanet also receives support from Searchlight Group. Visit Searchlight